Dr. Don Reynolds

Dr. Reynolds has held scientific, management and leadership positions in the Pharma, CRO and Consulting Services areas, and is the founder of a bioanalytical consulting company.  During his > 25 years of service he has acquired a broad-based understanding of the drug development process, and has experience with both new products and generics.  His expertise is in the areas of bioanalytical and pharmaceutical chemistry, quantitative separation science, and pharmacokinetics, in both GLP and non-GLP environments.  Dr. Reynolds received his doctoral degree in Pharmaceutical Chemistry from the University of Kansas after completing his Pharmacy degree at Ferris State College.  Dr. Reynolds has published and presented widely in the areas of method development strategies, assay methodology, new technologies and pharmacokinetics.  Dr. Reynolds is an active member of the American Association of Pharmaceutical Sciences (AAPS), and serves as a reviewer for the Journal of Chromatography B.   CV